₹ 1.0 Cr
Volume Transacted
(Nov 8, 2024)
7.8 K
Stocks Traded
(Nov 8, 2024)
Last Updated on: Nov 08, 2024
Dr Reddys Laboratories Ltd
NSE: DRREDDY
YEARLOW
₹ 1074.35
Last updated on: Nov 07, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
07 Nov 2024 | 1287.15 | 1304.05 | 1311.6 | 1281 |
06 Nov 2024 | 1303 | 1272.25 | 1322 | 1251.5 |
05 Nov 2024 | 1272.55 | 1277.4 | 1279.85 | 1241.4 |
04 Nov 2024 | 1267.95 | 1262.85 | 1276.75 | 1250.1 |
01 Nov 2024 | 1258.55 | 1281.95 | 1285 | 1213.2 |
31 Oct 2024 | 1274.25 | 1262.15 | 1283.25 | 1247.4 |
30 Oct 2024 | 1250.2 | 1275 | 1275 | 1229.1 |
29 Oct 2024 | 1275.1 | 1325.05 | 1333.65 | 1264.25 |
28 Oct 2024 | 1312.4 | 1328.9 | 1328.9 | 1291.6 |
25 Oct 2024 | 1302.83 | 1316 | 1316 | 1290.22 |
Date | Price (₹) |
---|---|
07 Nov 2024 | 1287.15 |
06 Nov 2024 | 1303 |
05 Nov 2024 | 1272.55 |
04 Nov 2024 | 1267.95 |
01 Nov 2024 | 1258.55 |
31 Oct 2024 | 1274.25 |
30 Oct 2024 | 1250.2 |
29 Oct 2024 | 1275.1 |
28 Oct 2024 | 1312.4 |
25 Oct 2024 | 1302.83 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Dr Reddys Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Dr Reddys Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Dr Reddys Laboratories Ltd spurts 2.25%
Dr Reddys Laboratories Ltd is up for a third straight session in a row. The stock is quoti...
06 Nov 202413:05
Dr Reddy's Q2 PAT slides 15% YoY to Rs 1,255 crore
Total revenue from operations stood at Rs 8,038.2 crore in Q2 FY25, up 16.45% YoY, primari...
05 Nov 202417:35
Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel
Aurigene Oncology, a wholly-owned subsidiary of Dr. Reddy's Laboratories has announced the...
08 Oct 202418:16
Dr Reddys announces incorporation of new step-down subsidiary in Denmark
Dr. Reddy's Laboratories SA, Switzerland, (DRSA) a wholly owned subsidiary of Dr Reddys ...
05 Oct 202411:37
Dr Reddys acquires Haleon plc brands in NRT category
Dr Reddys Laboratories announced that its wholly owned subsidiary, Dr. Reddy's Laboratorie...
30 Sep 202417:31
Dr Reddys Laboratories schedules board meeting
Dr Reddys Laboratories will hold a meeting of the Board of Directors of the Company on 5 N...
23 Sep 202410:11
FAQs for 52 Week Low of Dr Reddys Laboratories Ltd
Why is it important to track the 52-week low of Dr Reddys Laboratories Ltd stocks?
What factors can lead to Dr Reddys Laboratories Ltd stocks hitting a 52-week low?
Should investors buy Dr Reddys Laboratories Ltd stocks when they hit a 52-week low?
How often should investors monitor the 52-week low of Dr Reddys Laboratories Ltd stocks?
How can an investor assess the risk of buying Dr Reddys Laboratories Ltd stock at their 52-week low?
Should investors consider the overall market trend when evaluating Dr Reddys Laboratories Ltd stocks at their 52-week low?
Unlimited trading at just
Rs. 199*